SEC 13F Intelligence

Artia Global Partners LP / VRTX

Artia Global Partners LP’s Vertex Pharmaceuticals Inc Position

Does Artia Global Partners LP own Vertex Pharmaceuticals Inc (VRTX)? Not currently — the last reported position was 55.1K shares worth $22M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$22M
Q3 2025
Shares
55.1K
% of Portfolio
+3.42%
Quarters Held
9
position exited

Position History VRTX

Reported value by quarter
Q4 ’22: $2MQ4 ’22Q1 ’23: $2MQ2 ’23: $6MQ2 ’23Q3 ’23: $6MQ1 ’24: $12MQ1 ’24Q2 ’24: $9MQ3 ’24: $9MQ3 ’24Q2 ’25: $2MQ3 ’25: $22MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202555.1K$22M+3.42%
Q2 20254.4K$2M+0.47%
Q3 202418.9K$9M+2.40%
Q2 202418.9K$9M+1.71%
Q1 202428.9K$12M+2.43%
Q3 202318.3K$6M+2.65%
Q2 202318.3K$6M+2.22%
Q1 20237.1K$2M+0.83%
Q4 20227.1K$2M+0.78%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Artia Global Partners LP’s full portfolio or all institutional holders of VRTX.